ClinicalTrials.gg
CompletedNCT06637878WIBOFEUpdated Jun 5, 2026Results posted

SCT02 Clinical Accuracy Validation

An interventional study of Investigational Device (Withings SCT02) temporal thermometer measurement and Reference Device (Withings SCT01) temperature measurement in Fever, sponsored by Withings. Completed at 5 sites in United States. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Withings · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
118
Allocation
Non-randomized
Sex
All
01

Study summary

The aim of the study is to validate the accuracy of the temporal thermometer of Withings SCT02

02

Conditions studied

  • Fever

Browse trials for

03

In context

Fever

438 studies on the registry are indexed under Fever; 55 are open to participants now.

This study's enrollment of 118 is close to the median of 123 across 271 interventional studies indexed under Fever.

Browse Fever studies →

Lead sponsor

Withings is the lead sponsor of 23 studies on the registry; 3 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 2 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Consent: Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written and has received a signed and dated copy of the informed consent form.
  2. Age: Participant age is among the categories
  3. Compliance: Understands and is willing, able and likely to comply with all study procedures and restrictions.

Exclusion criteria

Exclusion Criteria

  1. Personnel: An employee of the sponsor or the study site or members of their immediate family.
  2. Medical Condition:

    1. Preterm infants (current age plus length of gestation is less than 40 weeks)
    2. Has taken antipyretic in previous 2 hours
    3. Inflammation at the measurement site
    4. Medical conditions that affect temperature readings (barbiturates, thyroid, antipsychotics, recent immunizations)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
118 participants (actual)

Study arms

  • Experimental
    Febrile - Investigational Device

    Temperature recording of patient with fever with investigational device

    Device: Investigational Device (Withings SCT02) temporal thermometer measurement

  • Active comparator
    Febrile - Comparator

    Temperature recording of patient with fever with predicate device

    Device: Reference Device (Withings SCT01) temperature measurement

Interventions

  • DeviceInvestigational Device (Withings SCT02) temporal thermometer measurement

    temperature measurement with investigational device (Withings SCT02)

  • DeviceReference Device (Withings SCT01) temperature measurement

    temperature measurement with reference device (Withings SCT01)

06

What researchers measure

Primary outcomes

  1. Clinical Bias

    Mean of the per-subject differences (Investigational - Reference), computed using the first measurement obtained from each subject with each device. A bias closer to 0 °F indicates closer agreement between devices; the sign indicates direction (a negative value means the investigational device read lower, on average, than the reference).

    Time frame: 1 visit

  2. Limits of Agreement

    Defined per ISO (International Standards Organization) 80601-2-56 as 2 × the standard deviation of the per-subject (Investigational - Reference) differences. A smaller value indicates tighter agreement between the two devices around the mean bias.

    Time frame: 1 visit

  3. Clinical Repeatability

    Pooled standard deviation of three repeated measurements taken on the same subject with the investigational device, calculated as σr = √\[(σ1² + σ2² + … + σN²) / N\], where σi is the within-subject standard deviation of the three repeats for subject i and N is the number of subjects with repeated measurements. A smaller value (closer to 0 °F) indicates greater consistency of repeated measurements on the same subject.

    Time frame: 1 visit

07

Results

Posted Jun 5, 2026
Limitations and caveats
Per ISO 80601-2-56, there are no established acceptance criteria; Quantities are reported for the BeamO device without judgment as to whether the results are acceptable or unacceptable.

Participant flow

Recruitment occurred at 5 clinical sites in the US from 8/31/2024 to 12/20/2024

Participant flow — Overall Study
MilestoneFebrile - Investigational Device and ComparatorAfebrile - Investigational Device and Comparator
Started3682
Completed3681
Not completed01

Outcome measures

PrimaryClinical Bias

Mean of the per-subject differences (Investigational - Reference), computed using the first measurement obtained from each subject with each device. A bias closer to 0 °F indicates closer agreement between devices; the sign indicates direction (a negative value means the investigational device read lower, on average, than the reference).

Time frame:
1 visit
Reported as:
Mean · Degrees Fahrenheit
Clinical Bias
Degrees FahrenheitAll Patients
Clinical Bias-0.074 ± 0.5115
PrimaryLimits of Agreement

Defined per ISO (International Standards Organization) 80601-2-56 as 2 × the standard deviation of the per-subject (Investigational - Reference) differences. A smaller value indicates tighter agreement between the two devices around the mean bias.

Time frame:
1 visit
Reported as:
Number · Degrees Fahrenheit
Limits of Agreement
Degrees FahrenheitAll Patients
Limits of Agreement1.023
PrimaryClinical Repeatability

Pooled standard deviation of three repeated measurements taken on the same subject with the investigational device, calculated as σr = √\[(σ1² + σ2² + … + σN²) / N\], where σi is the within-subject standard deviation of the three repeats for subject i and N is the number of subjects with repeated measurements. A smaller value (closer to 0 °F) indicates greater consistency of repeated measurements on the same subject.

Time frame:
1 visit
Reported as:
Number · Degrees Fahrenheit
Clinical Repeatability
Degrees FahrenheitAll Patients
Clinical Repeatability0.29

Adverse events

Collected over For the duration of the study visit (up to 1 hour). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Reference Device0/118 (0%)0/118 (0%)0/118 (0%)
Investigational Device0/118 (0%)0/118 (0%)0/118 (0%)

Baseline characteristics

11 protocol deviations leading to exclusion of participants from the efficacy analysis

Age, Customized
Age, Customized(Participants)Febrile - Investigational Device and ComparatorAfebrile - Investigational Device and ComparatorTotal
0 to <3 months01515
≥3 months to <1 year111021
≥1 to <5 years112536
≥5 years112435
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Febrile - Investigational Device and ComparatorAfebrile - Investigational Device and ComparatorTotal
Not Collected000
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Febrile - Investigational Device and ComparatorAfebrile - Investigational Device and ComparatorTotal
Count of participants——0
08

Study locations

5 sites
  • Diverse Clinical Research
    Miami, Florida 33175, United States
  • Dragonfly Primary Care
    Indianapolis, Indiana 46237, United States
  • New York City Health and Hospitals Corporation
    New York, New York 10029, United States
  • Integrated Family Care
    Cincinnati, Ohio 45206, United States
  • SES
    Mason, Ohio 45040, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06637878
Lead sponsor
Withings
Responsible party
Sponsor
First posted
Oct 15, 2024
Start date
Oct 3, 2024
Primary completion
Dec 20, 2024
Completion
Jan 8, 2025
Results posted
Jun 5, 2026
Last update
Jun 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion